Log In
Print
BCIQ
Print
Print this Print this
 

DCC-2701

  Manage Alerts
Collapse Summary General Information
Company Deciphera Pharmaceuticals LLC
DescriptionOral small molecule targeting vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2) and cMET receptor tyrosine kinase
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) (VEGFR-2) ; c-Met receptor tyrosine kinase
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationSolid tumors
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today